CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript

CRISPR Therapeutics AG (NASDAQ:CRSP) Company Conference Call June 11, 2024 9:20 AM ET Company Participants Sam Kulkarni - Chief Executive Officer Conference Call Participants Salveen Richter - Goldman Sachs Salveen Richter Good afternoon everyone, thank you for joining us. Really pleased to have Sam Kulkarni, CEO of CRISPR Therapeutics here with us. Sam, perhaps to start here, you have a couple of verticals - you have cancer, ex-vivo non-cancer, regenerative medicine, and in vivo verticals. Can you discus ...